Ellington Management Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,460
Closed -$173K 757
2018
Q2
$173K Buy
+5,460
New +$173K 0.01% 428